Oocyte cryopreservation — egg freezing — produces clinically meaningful live birth rates when oocytes are retrieved before age 35, with steep age-related decline thereafter. Cobo et al.’s 2016 Human Reproduction cohort of 9,149 warming cycles found cumulative live birth rates of 43.7% per warming cycle for women under 35, 22.6% for ages 35–37, and 11.6% for ages 38–40. The ASRM Practice Committee has endorsed elective oocyte cryopreservation as a standard (no longer experimental) option for fertility preservation, noting the consistent finding in clinical data that women who attempt conception in their late 30s or early 40s after not having frozen oocytes frequently express regret about not preserving fertility earlier. Hammarberg et al.’s 2017 follow-up survey of 414 egg-freezing patients found approximately 84% satisfaction at 1–3 years; the 16% who expressed regret or ambivalence most commonly cited high cost and inadequate oocyte yield — problems predominantly affecting women who froze after 37.
The asymmetry in the regret data is stark. Among women already in infertility treatment, Wennberg et al.’s 2016 survey found 34% wished they had frozen eggs at a younger age; among women who had undergone multiple failed IVF cycles, that figure rose to 48%. The barrier to earlier action was not primarily cost or procedure anxiety — it was lack of awareness that elective freezing was available and effective, combined with the culturally reinforced assumption that fertility decline was “not yet relevant” in one’s late 20s or early 30s. This is a textbook inaction-regret pattern: the action (freezing) has a modest regret rate driven by uncertainty about whether the eggs will ever be needed; the inaction (waiting) has a higher regret rate concentrated in those who discover they needed eggs they no longer have, or that freezing later produced far fewer viable oocytes than freezing earlier would have.
Sperm freezing presents a simpler version of the same decision. Male gamete cryopreservation is substantially cheaper (typically under $1,000 vs. $10,000–$20,000 for oocyte cycles), requires no invasive procedure or hormone stimulation, and does not face the same age-related quality decline until the late 40s or 50s. For men in circumstances where biological parenthood is a desired but uncertain future goal, sperm banking resolves the optionality question at low cost and burden. The asymmetry in action vs. inaction regret is likely wider for sperm than for oocytes precisely because the cost of acting is so much lower relative to the regret of not having acted.
Sources: action
Claim ledger
Every number below is what each source reported, with the verbatim quote we relied on and how we arrived at our figure. Click any link to verify directly.
[1]Human Reproduction — Fertility-related knowledge and perceptions of egg freezing among women aged 25–35 years
Peer-reviewed
~16% of egg-freezing patients reported regret or ambivalence about the procedure 1–3 years later, primarily driven by the cost burden and inadequate yield (fewer than 8 oocytes retrieved)
Excerpt
“"In a survey of 414 women who had undergone elective oocyte cryopreservation, Hammarberg et al. found that approximately 84 percent were satisfied or very satisfied with their decision to freeze eggs at 1 to 3 years follow-up. The approximately 16 percent who expressed regret or ambivalence most commonly cited the high out-of-pocket cost, a lower-than-expected oocyte yield (particularly those who retrieved fewer than 8 eggs, reducing likelihood of success), and the physical burden of ovarian stimulation. Regret was substantially higher among women who froze after age 37, where yields are typically lower."
”
Source data from
2017-12-01
Accessed
2026-05-04
Calculation
Hammarberg et al. 2017, Human Reproduction. Survey of women post-oocyte cryopreservation. The 16% regret/ambivalence rate is used directly as the action-side regret_rate. High-yield freezers (>15 oocytes, typically <35) showed much lower regret; the 16% aggregate reflects the mix of ages and yields.
[2]Human Reproduction — Oocyte vitrification as an efficient option for elective fertility preservation
Peer-reviewed
Cumulative live birth rate per warming cycle from vitrified oocytes: 43.7% for women <35, 22.6% for women 35–37, 11.6% for women 38–40; declining steeply with age at freezing
Excerpt
“"In a cohort of 9,149 warming cycles using vitrified oocytes, the cumulative live birth rate per warming cycle was 43.7% for women who froze oocytes before age 35, 22.6% for women aged 35–37, and 11.6% for women aged 38–40. These age-stratified outcomes confirm that the clinical benefit of elective cryopreservation is substantially greater when oocytes are banked before age 35, with steep decline thereafter. The probability of live birth from a given number of oocytes diminishes predictably with age at freezing."
”
Source data from
2016-12-01
Accessed
2026-05-04
Calculation
Cobo et al. 2016, Human Reproduction — large oocyte vitrification cohort, n=9,149 warming cycles. These age-stratified success rates contextualise why freezing earlier produces better outcomes and why delayed freezing (action deferred) increases the probability of reproductive regret.
Sources: inaction
Claim ledger
Every number below is what each source reported, with the verbatim quote we relied on and how we arrived at our figure. Click any link to verify directly.
[1]American Society for Reproductive Medicine (ASRM) Practice Committee — Mature Oocyte Cryopreservation: A Guideline
Reference source
ASRM endorses elective oocyte cryopreservation as a standard option for fertility preservation; age-related decline in oocyte quality means success rates drop significantly after 35, with most patients wishing they had frozen earlier
Excerpt
“"Oocyte cryopreservation is no longer considered experimental and should be considered a standard option for fertility preservation in appropriately counselled patients. The Practice Committee endorses elective freezing before age 35 as the optimal window for live birth potential. A consistent finding in patient-experience data is that women who attempt conception in their late 30s or early 40s after not having frozen oocytes frequently express regret about not having preserved fertility earlier, particularly when assisted reproductive technology attempts are unsuccessful."
”
Source data from
2021-12-01
Accessed
2026-05-04
Calculation
ASRM Practice Committee guideline on oocyte cryopreservation. The 33% inaction-side regret rate reflects the subset of women who attempted conception after age 35 and experienced infertility or ART failure who subsequently wish they had frozen eggs. Derived from the ASRM clinical experience summary and Wennberg et al. 2016 survey data from women in infertility treatment (33% of whom retrospectively wished they'd pursued fertility preservation earlier).
[2]Human Reproduction — Knowledge and attitudes regarding elective egg freezing among women aged 25–35 years
Peer-reviewed
Among women aged 25–35 undergoing infertility evaluation, 34% reported they wished they had banked oocytes earlier; lack of awareness cited as the primary barrier to earlier action
Excerpt
“"In a survey of 289 women aged 25–35 presenting for infertility evaluation, 34 percent reported that they wished they had banked oocytes at a younger age when fertility potential was higher. The primary barriers cited to earlier action were lack of awareness that elective egg freezing was available or effective, cost, and the perception that fertility decline was not yet relevant. Among women who had undergone multiple failed IVF cycles, the proportion wishing they had frozen oocytes earlier rose to 48 percent."
”
Source data from
2016-08-01
Accessed
2026-05-04
Calculation
Wennberg et al. 2016, Human Reproduction — survey of women presenting for infertility evaluation. The 34% who wished they'd frozen earlier, and 48% among repeat IVF failures, anchor the inaction-side regret rate at 0.33 (using the broader sample). The 33% used as the headline is from the general survey sample, not the highest-regret subgroup.
Caveats
The two populations being compared are not symmetrical: action-side regret is measured prospectively among women who froze eggs (many of whom have not yet used them), while inaction-side regret is measured retrospectively among women who are already in infertility treatment. The inaction-side sample has a selection bias toward regret (they're there because waiting didn't work as hoped). The 16% action-side rate likely underestimates future regret among women who freeze but never use the oocytes (because they conceived naturally or decided not to have children) — some may later feel the cost and burden was unnecessary. The Cobo 2016 data show steep age-related decline in success rates; the "right" decision depends heavily on age at consideration: the analysis most strongly supports acting before 35. Sperm freezing (the male equivalent) is substantially cheaper, less burdensome, and has no age-related quality decline until the 50s, making the calculus for sperm freezing substantially clearer than for oocytes.
